700 related articles for article (PubMed ID: 30648791)
1. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y
J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791
[TBL] [Abstract][Full Text] [Related]
2. FTO is required for myogenesis by positively regulating mTOR-PGC-1α pathway-mediated mitochondria biogenesis.
Wang X; Huang N; Yang M; Wei D; Tai H; Han X; Gong H; Zhou J; Qin J; Wei X; Chen H; Fang T; Xiao H
Cell Death Dis; 2017 Mar; 8(3):e2702. PubMed ID: 28333151
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C beta relieves autism-like behavior in EN2 knockout mice via upregulation of the FTO/PGC-1α/UCP1 axis.
Song X; Hu Q; Xu X; Pan W
J Biochem Mol Toxicol; 2023 Jan; 37(1):e23236. PubMed ID: 36239013
[TBL] [Abstract][Full Text] [Related]
4. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival.
Zhao J; Lu L
Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
6. The m
Xiao Y; Thakkar KN; Zhao H; Broughton J; Li Y; Seoane JA; Diep AN; Metzner TJ; von Eyben R; Dill DL; Brooks JD; Curtis C; Leppert JT; Ye J; Peehl DM; Giaccia AJ; Sinha S; Rankin EB
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21441-21449. PubMed ID: 32817424
[TBL] [Abstract][Full Text] [Related]
7. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability.
Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177
[TBL] [Abstract][Full Text] [Related]
8. MPC1 is essential for PGC-1α-induced mitochondrial respiration and biogenesis.
Koh E; Kim YK; Shin D; Kim KS
Biochem J; 2018 May; 475(10):1687-1699. PubMed ID: 29669911
[TBL] [Abstract][Full Text] [Related]
9. Aberrant activation of m6A demethylase FTO renders HIF2α
Zhang C; Chen L; Lou W; Su J; Huang J; Liu A; Xu Y; He H; Gao Y; Xu D; Li Q
Sci Transl Med; 2021 Sep; 13(613):eabf6045. PubMed ID: 34586831
[TBL] [Abstract][Full Text] [Related]
10. Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma.
LaGory EL; Wu C; Taniguchi CM; Ding CC; Chi JT; von Eyben R; Scott DA; Richardson AD; Giaccia AJ
Cell Rep; 2015 Jul; 12(1):116-127. PubMed ID: 26119730
[TBL] [Abstract][Full Text] [Related]
11. MiR-155 regulates m
Yang W; Xie L; Wang P; Zhuang C
Cell Signal; 2022 Mar; 91():110217. PubMed ID: 34921979
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer.
Wu J; Wang X; Li X
Epigenomics; 2022 Dec; 14(23):1509-1522. PubMed ID: 36815224
[TBL] [Abstract][Full Text] [Related]
14. The m
He Y; Chen Y; Li Z; Wu C
J Cancer Res Clin Oncol; 2024 Jan; 150(2):30. PubMed ID: 38270643
[TBL] [Abstract][Full Text] [Related]
15. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
16. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
17. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
18. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
Azzam SK; Alsafar H; Sajini AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
[TBL] [Abstract][Full Text] [Related]
19. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.
Qian X; Li X; Shi Z; Bai X; Xia Y; Zheng Y; Xu D; Chen F; You Y; Fang J; Hu Z; Zhou Q; Lu Z
Mol Cell; 2019 Dec; 76(6):885-895.e7. PubMed ID: 31629659
[TBL] [Abstract][Full Text] [Related]
20. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
